LENALIDOMIDE TREATMENT IN 5Q(-) SYNDROME: A SINGLE CENTER EXPERIENCE

被引：0
|
作者：
Uskudar, H. Teke [1 ]
Andic, N. [1 ]
Gunduz, E. [1 ]
Ozpolat, S. [2 ]
Aras, B. Durak [2 ]
Akay, O. [1 ]
机构：
[1] Eskisehir Osmangazi Univ, Fac Med, Hematol, Eskisehir, Turkey
[2] Eskisehir Osmangazi Univ, Fac Med, Genet, Eskisehir, Turkey
来源：
LEUKEMIA RESEARCH | 2015年 / 39卷
关键词：
D O I：
10.1016/S0145-2126(15)30198-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
197
引用
收藏
页码：S98 / S99
页数：2
相关论文
共 50 条
  • [41] Myelodysplastic syndromes with 5q deletion: pathophysiology and role of lenalidomide
    Mahmoud R. Gaballa
    Emmanuel C. Besa
    Annals of Hematology, 2014, 93 : 723 - 733
  • [42] Real-world Data From the Swiss Lenalidomide in MDS del(5q) (SLIM)-Registry Identify New Chances and Challenges in Lenalidomide Treatment of Patients With MDS del(5q)
    Rufer, Axel
    Angermann, Hubert
    Benz, Rudolf
    Bonadies, Nicolas
    Calderoni, Antonello
    Cantoni, Nathan
    Efthymiou, Anna
    Escher, Robert
    Favre, Genevieve
    Friess, Dorothea
    Gschwend, Andreas
    Himmelmann, Andreas
    Holbro, Andreas
    Keller, Peter
    Kouroupi, Eirini
    Lehmann, Thomas
    Pedarnig, Nikolaus
    Rigamonti, Veronique
    Samii, Kaveh
    Schmidt, Adrian
    Schafer, Hans-Peter
    Sperb, Roland
    Stussi, Georg
    Winkler, Annette
    Zenhausern, Reinhard
    Goede, Jeroen S.
    HEMASPHERE, 2022, 6 (07):
  • [43] Lenalidomide in patients with red blood cell transfusion-dependent myelodysplastic syndrome and del(5q): a single-centre "real-world" experience
    Cerqui, Elisa
    Pelizzari, Annamaria
    Schieppati, Francesca
    Borlenghi, Erika
    Pagani, Chiara
    Bellotti, Daniela
    Lamorgese, Cinzia
    Boiocchi, Leonardo
    Sottini, Alessandra
    Imberti, Luisa
    Rossi, Giuseppe
    LEUKEMIA & LYMPHOMA, 2015, 56 (11) : 3129 - 3134
  • [44] Myelodysplastic syndromes with 5q deletion: pathophysiology and role of lenalidomide
    Gaballa, Mahmoud R.
    Besa, Emmanuel C.
    ANNALS OF HEMATOLOGY, 2014, 93 (05) : 723 - 733
  • [45] Genome-wide miRNA profiling in myelodysplastic syndrome with del(5q) treated with lenalidomide
    Merkerova, Michaela Dostalova
    Krejcik, Zdenek
    Belickova, Monika
    Hrustincova, Andrea
    Klema, Jiri
    Stara, Eliska
    Zemanova, Zuzana
    Michalova, Kyra
    Cermak, Jaroslav
    Jonasova, Anna
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 95 (01) : 35 - 43
  • [46] Effect of lenalidomide therapy on hematopoiesis of patients with myelodysplastic syndrome associated with chromosome 5q deletion
    Ximeri, Maria
    Galanopoulos, Athanasios
    Klaus, Mirjam
    Parcharidou, Agapi
    Giannikou, Krinio
    Psyllaki, Maria
    Symeonidis, Argyrios
    Pappa, Vasiliki
    Kartasis, Zafiris
    Liapi, Dimitra
    Hatzimichael, Eleftheria
    Kokoris, Styliani
    Korkolopoulou, Penelope
    Sambani, Constantina
    Pontikoglou, Charalampos
    Papadaki, Helen A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (03): : 406 - 414
  • [47] TELOMERE SHORTENING AND AML PROGRESSION IN PATIENTS WITH MYELODYSPLASTIC SYNDROME AND DELETION 5Q TREATED WITH LENALIDOMIDE
    Goehring, G.
    Lange, K.
    Hofmann, W.
    Buesche, G.
    Kreipe, H.
    Hellstroem-Lindberg, E.
    Giagounidis, A.
    Schlegelberger, B.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 378 - 379
  • [48] Comparison of the Molecular Spectrum of Lenalidomide-Treated Myelodysplastic Syndrome with and without Del(5q)
    Adema, Vera
    Palomo, Laura
    Fuster-Tormo, Francisco
    Benito, Rocio
    Salgado, Rocio
    Such, Esperanza
    Kosmider, Olivier
    Larrayoz, Maria Jose
    Xicoy, Blanca
    Janusz, Kamila
    Maietta, Paolo
    Neef, Alexander
    Amunchastegui, Beatriz Arrizabalaga
    Fontenay, Michaela
    Gomez-Marzo, Paula
    Del Rey, Monica
    Ibanez, Mariam
    Haro, Nuri
    Mallo, Mar
    Zamora, Lurdes
    Visconte, Valeria
    Maciejewski, Jaroslaw P.
    Fenaux, Pierre
    Cervera, Jose
    Calasanz, Maria Jose
    Hernandez-Rivas, Jesus Maria
    Cigudosa, Juan
    Sole, Francesc
    BLOOD, 2016, 128 (22)
  • [49] Treating non-del 5q patients with lenalidomide
    Schiffer, C. A.
    LEUKEMIA RESEARCH, 2007, 31 : S9 - S10
  • [50] Frequency of venous thrombotic events in patients with myelodysplastic syndrome and 5q deletion syndrome during lenalidomide therapy
    Omar A. Alkharabsheh
    Salwa S. Saadeh
    Darci L. Zblewski
    Naseema Gangat
    Kebede H. Begna
    Michelle A. Elliott
    Hassan B. Alkhateeb
    Mrinal S. Patnaik
    William J. Hogan
    Mark R. Litzow
    Aref Al-Kali
    Annals of Hematology, 2019, 98 : 331 - 337
12345